SPY400.09-1.63 -0.41%
DIA322.78+0.55 0.17%
IXIC11,662.79-142.21 -1.20%

BRIEF-BioRestorative Therapies Hosts Principal Investigator Meeting for BRTX-100 Trial

reuters.com · 04/29/2022 08:02
BRIEF-BioRestorative Therapies Hosts Principal Investigator Meeting for BRTX-100 Trial

- BioRestorative Therapies Inc BRTX:

  • BIORESTORATIVE THERAPIES HOSTS PRINCIPAL INVESTIGATOR MEETING FOR ITS BRTX-100® PHASE 2 CLINICAL TRIAL TO TREAT CHRONIC LUMBAR DISC DISEASE

Source text for Eikon: ID:nGNX4HsTw

Further company coverage: BRTX


((Reuters.Briefs@thomsonreuters.com;))